Avantor, Inc., a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, announced the appointment of
Hallmark Health Care Solutions, the leader in Workforce Intelligence and Enablement, announced the appointment of Robert Musslewhite to its Board of Directors. A veteran public
KalVista Pharmaceuticals, Inc. announced the appointment of Bethany L. Sensenig to its Board of Directors, effective October 1, 2025. Along with joining the Board, Ms.
AmeriPro Health, a top company in patient transportation and using technology to improve medical care, has announced that its Board of Directors has selected Larry
Avalo Therapeutics, a clinical stage biotechnology company fully dedicated to developing IL-1β-based treatments for immune-mediated inflammatory diseases, announced the appointment of Kevin R. Lind to
Kewaunee Scientific Corporation, a top company in designing, making, and installing lab, healthcare, and technical furniture, recently announced that J. Jette Campbell, CPA, has joined
Dr. Blackman is an Entrepreneur-in-Residence at Google Ventures and a former senior pharma executive with a track record of leading the development of innovative cancer
Cencora, Inc. has announced that its Board of Directors has appointed D. Mark Durcan as the new Chairman of the Board, effective October 1, 2025.
BoldAge PACE, a leading organization in the Program of All-Inclusive Care for the Elderly, has added healthcare professional Brian Clem to its Board of Directors.
Appointment recognizes Mr. Durso’s extensive commercial expertise as Altimmune prepares for Phase 3 development of pemvidutide in MASH Altimmune, Inc., a late clinical-stage biopharmaceutical company
Aktis Oncology, Inc., a clinical-stage company focused on advancing radiopharmaceutical therapies for cancers not addressed by current platforms, has announced that Mike Sherman has joined
Aqueous Health announced that healthcare industry veteran, Robert (Bob) J Zollars has joined its Board of Directors. “We are very pleased to have Bob on our
